BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kerola A, Lampela H, Lohi J, Heikkilä P, Mutanen A, Hagström J, Tervahartiala T, Sorsa T, Haglund C, Jalanko H, Pakarinen MP. Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia. J Pathol Clin Res 2016;2:187-98. [PMID: 27499927 DOI: 10.1002/cjp2.50] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Dawood RM, El-meguid MA, Salum GM, El Awady MK. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020;40:472-89. [DOI: 10.1089/jir.2020.0059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yang L, Zhou Y, Xu PP, Mourya R, Lei HY, Cao GQ, Xiong XL, Xu H, Duan XF, Wang N, Fei L, Chang XP, Zhang X, Jiang M, Bezerra JA, Tang ST. Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia. Hepatology 2018;68:2069-77. [PMID: 30153340 DOI: 10.1002/hep.30234] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
3 Harpavat S. MMP-7: The Next Best Serum Biomarker for Biliary Atresia? J Pediatr 2019;208:8-9. [PMID: 30857775 DOI: 10.1016/j.jpeds.2019.01.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
4 Naim A, Pan Q, Baig MS. Matrix Metalloproteinases (MMPs) in Liver Diseases. J Clin Exp Hepatol. 2017;7:367-372. [PMID: 29234202 DOI: 10.1016/j.jceh.2017.09.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
5 Wu JF, Jeng YM, Chen HL, Ni YH, Hsu HY, Chang MH. Quantification of Serum Matrix Metallopeptide 7 Levels May Assist in the Diagnosis and Predict the Outcome for Patients with Biliary Atresia. J Pediatr 2019;208:30-37.e1. [PMID: 30853207 DOI: 10.1016/j.jpeds.2018.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
6 Lertudomphonwanit C, Mourya R, Fei L, Zhang Y, Gutta S, Yang L, Bove KE, Shivakumar P, Bezerra JA. Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia. Sci Transl Med 2017;9:eaan8462. [PMID: 29167395 DOI: 10.1126/scitranslmed.aan8462] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
7 Hukkinen M, Pihlajoki M, Pakarinen MP. Predicting native liver injury and survival in biliary atresia. Seminars in Pediatric Surgery 2020;29:150943. [DOI: 10.1016/j.sempedsurg.2020.150943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Kerola A, Lohi J, Heikkilä P, Mutanen A, Jalanko H, Pakarinen MP. Divergent expression of liver transforming growth factor superfamily cytokines after successful portoenterostomy in biliary atresia. Surgery 2019;165:905-11. [PMID: 30686515 DOI: 10.1016/j.surg.2018.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kerola A, Lampela H, Lohi J, Heikkilä P, Mutanen A, Jalanko H, Pakarinen MP. Molecular signature of active fibrogenesis prevails in biliary atresia after successful portoenterostomy. Surgery 2017;162:548-56. [PMID: 28655415 DOI: 10.1016/j.surg.2017.04.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
10 Nomden M, Beljaars L, Verkade HJ, Hulscher JBF, Olinga P. Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature. Front Med (Lausanne) 2020;7:617261. [PMID: 33409288 DOI: 10.3389/fmed.2020.617261] [Reference Citation Analysis]
11 Määttä M, Laurila HP, Holopainen S, Aaltonen K, Lilja-Maula L, Viitanen S, Rajamäki MM. Matrix metalloproteinase-2, -7, and -9 activities in dogs with idiopathic pulmonary fibrosis compared to healthy dogs and dogs with other respiratory diseases. J Vet Intern Med 2021;35:462-71. [PMID: 33274549 DOI: 10.1111/jvim.15970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kyrönlahti A, Godbole N, Akinrinade O, Soini T, Nyholm I, Andersson N, Hukkinen M, Lohi J, Wilson DB, Pihlajoki M, Pakarinen MP, Heikinheimo M. Evolving Up-regulation of Biliary Fibrosis-Related Extracellular Matrix Molecules After Successful Portoenterostomy. Hepatol Commun 2021;5:1036-50. [PMID: 34141988 DOI: 10.1002/hep4.1684] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Geervliet E, Bansal R. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases. Cells. 2020;9. [PMID: 32414178 DOI: 10.3390/cells9051212] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
14 Ramachandran P, Balamurali D, Peter JJ, Kumar MM, Safwan M, Vij M, Rela M, Mahalingam S. RNA-seq reveals outcome-specific gene expression of MMP7 and PCK1 in biliary atresia. Mol Biol Rep 2019;46:5123-30. [PMID: 31342296 DOI: 10.1007/s11033-019-04969-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Lee CZ, Peng SS, Lee CS, Chen HL, Ni YH, Chang MH, Wu JF. Transient elastography correlated with diffusion-weighted magnetic resonance imaging and cholestatic complications. J Formos Med Assoc 2019;118:1522-7. [PMID: 30621960 DOI: 10.1016/j.jfma.2018.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Osborn J, Mourya R, Thanekar U, Su W, Fei L, Shivakumar P, Bezerra JA. Serum Proteomics Uncovers Biomarkers of Clinical Portal Hypertension in Children With Biliary Atresia. Hepatol Commun 2021. [PMID: 34962102 DOI: 10.1002/hep4.1878] [Reference Citation Analysis]
17 Hukkinen M, Kerola A, Lohi J, Heikkilä P, Merras-Salmio L, Jahnukainen T, Koivusalo A, Jalanko H, Pakarinen MP. Treatment Policy and Liver Histopathology Predict Biliary Atresia Outcomes: Results after National Centralization and Protocol Biopsies. J Am Coll Surg 2018;226:46-57.e1. [PMID: 28958913 DOI: 10.1016/j.jamcollsurg.2017.09.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
18 Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, Sokol RJ. Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century. Hepatology 2018;68:1163-73. [PMID: 29604222 DOI: 10.1002/hep.29905] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 21.3] [Reference Citation Analysis]
20 Hukkinen M, Kerola A, Lohi J, Jahnukainen T, Heikkilä P, Pakarinen MP. Very low bilirubin after portoenterostomy improves survival of the native liver in patients with biliary atresia by deferring liver fibrogenesis. Surgery 2019;165:843-50. [PMID: 30514566 DOI: 10.1016/j.surg.2018.10.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Lam S, Singh R, Dillman JR, Trout AT, Serai SD, Sharma D, Sheridan R, Su W, Fei L, Karns R, Haramija MM, Ridgway G, Goldfinger M, Squires JE, Denson LA, Hyams JS, Miethke AG. Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease. Hepatol Commun 2020;4:1680-93. [PMID: 33163837 DOI: 10.1002/hep4.1589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Al-Humadi H, Alhumadi A, Al-Saigh R, Strilakou A, Lazaris AC, Gazouli M, Liapi C. "Extracellular matrix remodelling in the liver of rats subjected to dietary choline deprivation and/or thioacetamide administration". Clin Exp Pharmacol Physiol 2018;45:1245-56. [PMID: 30019784 DOI: 10.1111/1440-1681.13013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Shen WJ, Chen G, Wang M, Zheng S. Liver fibrosis in biliary atresia. World J Pediatr 2019;15:117-23. [PMID: 30465125 DOI: 10.1007/s12519-018-0203-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
24 Wehrman A, Waisbourd-Zinman O, Wells RG. Recent advances in understanding biliary atresia. F1000Res 2019;8:F1000 Faculty Rev-218. [PMID: 30828434 DOI: 10.12688/f1000research.16732.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
25 He L, Ip DKM, Tam G, Lui VCH, Tam PKH, Chung PHY. Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis. Sci Rep 2021;11:11692. [PMID: 34083585 DOI: 10.1038/s41598-021-91072-y] [Reference Citation Analysis]
26 Irvine KM, Okano S, Patel PJ, Horsfall LU, Williams S, Russell A, Powell EE. Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep 2021;11:2858. [PMID: 33536476 DOI: 10.1038/s41598-021-82315-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]